Literature DB >> 14476725

In vitro activity of a combination of colimycin and tetracycline against Pseudomonas aeruginosa and Escherichia coli.

R P MOUTON.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/pharmacology; ESCHERICHIA COLI/pharmacology; PSEUDOMONAS/pharmacology; TETRACYCLINE/pharmacology

Mesh:

Substances:

Year:  1961        PMID: 14476725     DOI: 10.1007/BF02538469

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


× No keyword cloud information.
  9 in total

1.  [Kanamycin, a new antibiotic; experimental study in vitro].

Authors:  G ANDRIEU; J MONNIER; R BOURSE
Journal:  Presse Med       Date:  1959-04-11       Impact factor: 1.228

2.  Treatment of chronic pyelonephritis. III. Comparison of several drugs combined and one member of the combination, colistin.

Authors:  W R MCCABE; G G JACKSON
Journal:  Am J Med Sci       Date:  1960-12       Impact factor: 2.378

3.  The synergism between penicillin and kanamycin.

Authors:  R P MOUTON
Journal:  Antonie Van Leeuwenhoek       Date:  1961       Impact factor: 2.271

4.  The rationale and management of combined therapy.

Authors:  B W LACEY
Journal:  Br Med Bull       Date:  1960-01       Impact factor: 4.291

5.  Laboratory aspects of combined antibiotic treatment.

Authors:  S D ELEK; G R HILSON; P JEWELL
Journal:  Br Med J       Date:  1953-12-12

6.  The pattern of combined effect of polymyxin B and oxytetracycline in vitro on Pseudomonas aeruginosa.

Authors:  J B VACCA
Journal:  Antibiot Chemother (Northfield)       Date:  1956-02

7.  [Chemotherapeutic resistance of Pseudomonas aeruginosa].

Authors:  G HENNEBERG; E M MULLER
Journal:  Zentralbl Bakteriol Orig       Date:  1954

8.  Replica plating and indirect selection of bacterial mutants.

Authors:  J LEDERBERG; E M LEDERBERG
Journal:  J Bacteriol       Date:  1952-03       Impact factor: 3.490

9.  The protection of intracellular brucella against therapeutic agents and the bactericidal action of serum.

Authors:  J M SHAFFER; C J KUCERA; W W SPINK
Journal:  J Exp Med       Date:  1953-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.